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Abstract
The NLRP3 inflammasome complex is responsible for maturation of the pro-inflammatory cytokine, IL-1b. Mutations in
NLRP3 are responsible for the cryopyrinopathies, a spectrum of conditions including neonatal-onset multisystem
inflammatory disease (NOMID). While excessive production of IL-1b and systemic inflammation are common to all
cryopyrinopathy disorders, skeletal abnormalities, prominently in the knees, and low bone mass are unique features of
patients with NOMID. To gain insights into the mechanisms underlying skeletal abnormalities in NOMID, we generated
knock-in mice globally expressing the D301N NLRP3 mutation (ortholog of D303N in human NLRP3). NOMID mice exhibit
neutrophilia in blood and many tissues, including knee joints, and high levels of serum inflammatory mediators. They also
exhibit growth retardation and severe postnatal osteopenia stemming at least in part from abnormally accelerated bone
resorption, attended by increased osteoclastogenesis. Histologic analysis of knee joints revealed abnormal growth plates,
with loss of chondrocytes and growth arrest in the central region of the epiphyses. Most strikingly, a tissue ‘‘spike’’ was
observed in the mid-region of the growth plate in the long bones of all NOMID mice that may be the precursor to more
severe deformations analogous to those observed in NOMID patients. These findings provide direct evidence linking a
NOMID-associated NLRP3-activating mutation to abnormalities of postnatal skeletal growth and bone remodeling.
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Introduction
NLRP3, also called cryopyrin, is one of the most studied
members of the NOD-like receptor (NLR) family, which are
intracellular proteins involved in the initiation of the innate
immune response. NLRP3 is capable of forming an inflammasome
[1,2], an intracellular protein complex responsible for activation of
caspase 1 and the subsequent processing of pro-IL-1b and pro-IL-
18 into mature IL-1b and IL-18, respectively. The NLRP3
inflammasome is activated by multiple danger-associated moieties,
including ATP, glucose, monosodium urate, calcium pyrophos-
phate dihydrate and cholesterol crystals [3–5]. Dysregulated
activation of this inflammasome is believed to be involved in the
pathogenesis of various inflammatory and metabolic diseases such
as gout, pseudogout, type-2 diabetes and atherosclerosis [3,5–7].
Approximately 80 pathogenic mutations in the NLRP3 gene
have been identified in patients with systemic autoinflammatory
disorders known as cryopyrinopathies or cryopyrin-associated
periodic syndromes (CAPS), which include neonatal-onset multi-
system inflammatory disease (NOMID), Muckle-Wells syndrome
(MWS) and familial cold autoinflammatory syndrome (FCAS) [8].
NLRP3 mutations are thought to cause constitutive inflammasome
activation with some degree of genotype-phenotype correlation
[9]. Each of the CAPS phenotypes is associated with excessive
cytokine production, recurrent or chronic fever, urticaria-like rash,
and joint and CNS symptoms. However, skeletal malformations
are unique features of NOMID [10,11], and a report on a cohort
of NOMID patients revealed that the majority of these patients
have bone deformities and/or are osteoporotic. Abnormal
endochondral ossification was suspected in these patients [12].
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35979Intramembranous and endochondral ossifications are two
processes that with few exceptions, govern the development of
flat and long bones, respectively. In the former process
mesenchymal condensations form bone directly, whereas in the
latter, they differentiate into chondrocytes which form the
cartilage template for bone development [13]. After development,
balanced bone formation and resorption ensures bone homeosta-
sis. While unsynchronized events during development cause bone
malformations, excessive bone resorption leads to bone loss. This
loss occurs in a variety of pathological conditions in which the
production of pro-inflammatory cytokines is increased, including
postmenopausal osteoporosis, inflammatory diseases such as
rheumatoid arthritis and aseptic implant loosening, and infectious
diseases including endotoxemia and periodontitis [14,15]. Cyto-
kines such as IL-1b, IL-6 and tumor necrosis factor-a (TNF-a)
have dual negative effects on bone health as they inhibit bone
formation and enhance bone resorption [16,17]. While bone
formation is the function of osteoblasts (OB), bone resorption is the
main function of osteoclasts (OC), hematopoietic cells of the
monocyte/macrophage lineage [18]. Differentiation, survival and
activity of OC depend upon the expression of RANKL, a TNF
family member [18]. Pro-inflammatory cytokines regulate both
RANKL expression and act in synergy with this factor to
propagate inflammation-associated bone erosion [19]. Since high
serum and tissue levels of IL-1b and IL-6 are characteristic of
CAPS, it is reasonable to hypothesize that inflammatory bone loss
occurs in this autoinflammatory disease spectrum and perhaps
other NLRP3-associated disorders.
To model the human NOMID syndrome and to achieve
insights into its associated skeletal abnormalities, we generated
mice globally expressing the D301N mutation in Nlrp3, corre-
sponding to the D303N mutation in human NLRP3, linked to
NOMID. NOMID mice phenocopy several features of human
NOMID such as early onset systemic inflammation and growth
retardation. These mice also have disorganized growth plates and
low bone mass associated with exuberant osteoclastogenesis,
suggesting a strong link between this NOMID associated mutation
and abnormal skeletal development.
Results
NOMID mice exhibit systemic inflammation and reduced
survival
The aspartate 303 to asparagine (D303N) substitution has been
identified in NOMID and severe MWS patients [10,11]. This
autosomal dominant point mutation occurs near the Mg
2+ binding
site in the NLRP3 NACHT domain and is thought to cause a
conformational change that confers ligand-independent constitu-
tive activation of the mutated NLRP3 inflammasome. To further
understand the pathological impact of this mutation, we generated
knock-in mice expressing D301N NLRP3 (D303N ortholog of
human NLRP3) using a previously described strategy [20]. Due to
the presence of an intronic FLOXed neomycin resistance cassette,
the expression of the mutation does not occur unless knock-in mice
are first bred with mice expressing Cre recombinase (Fig. S1).
Zona pelucida 3-Cre was used to induce global expression of
D301N NLRP3 similar to that observed in NOMID patients.
NOMID pups were born at the expected Mendelian frequency.
Although often indistinguishable from wild-type (WT) siblings at
birth, NOMID mice exhibited growth retardation and significant-
ly lower body weight obvious by post birth day 5 (P5) (Fig. 1A),
and the mice usually died by 2–3 weeks of age (Fig. 1B). Body fat
mass measured at P13 by dual-energy X-ray absorptiometry
(DXA) was not significantly different between NOMID and WT
mice (21.660.5% vs. 20.660.5%, respectively; p.0.10, n=5).
Haematoxylin and eosin (H&E) staining showed granulocytic
infiltrates in various tissues, including joints (Fig. 1C) and
meninges (Fig. S2). Complete blood cell counts further revealed
that NOMID mice exhibited peripheral neutrophilic leukocytosis,
with accompanying thrombocytosis, severe lymphopenia and
anemia (Fig. 2A). This phenotype is reminiscent of other models
of Nlrp3 variants [20,21], and more importantly, of CAPS patients.
To gain further insights into the phenotype of NOMID mice,
we measured the serum levels of inflammatory mediators. Serum
IL-1b and IL-18 as well as the granulocyte growth factor, G-CSF,
were significantly increased in serum from NOMID mice
compared to WT mice (Fig. 2B). Serum levels of IL-3, IL-4, IL-
6, IL-9, IL-13, GM-CSF, IFN-c, TNF-a and several chemokines
(e.g., Eotaxin, KC, MCP-1, MIP-1a, MIP-1b and RANTES) were
also higher in NOMID mice (Fig. 2B and Fig. S3). In contrast,
cytokines of activated T cells such as IL-2, IL-10 and IL-17 were
not up-regulated in NOMID mice. These findings are in
agreement with our previous results [20] and the notion that
CAPS are primarily disorders of the innate immune system. While
IL-1a levels were also not significantly different between
genotypes, IL-5 and IL-12(p40) levels were lower in NOMID
mice (Fig. S3). The significance of this finding is not clear. Thus,
NOMID mice exhibit the systemic inflammation, hematologic
features, cytokine levels, and poor growth characteristic of the
human disease, validating the use of this model in further
understanding the pathological consequences of NOMID.
NOMID mice exhibit stunted skeletal growth,
disorganized growth plates and reduced bone mass
NOMID-associated NLRP3 mutations cause skeletal malforma-
tions and low bone mass not generally observed in MWS or FCAS
[10,11]. We therefore asked whether the massive leukocytic
infiltration noted in NOMID mouse joints (Fig. 1C) might be
associated with a bone phenotype similar to that observed in
patients. By high resolution radiography, the skeleton of NOMID
mice at age P13 was markedly smaller than WT littermates
(Fig. 3A). Importantly, NOMID mice were significantly osteopenic
relative to WT mice based on DXA analysis of whole body bone
mineral density (BMD), which includes cortical and trabecular
compartments of the axial and appendicular skeleton (Fig. 3B).
Furthermore, 3D reconstruction of bone architecture by micro-
computed tomography (mCT) demonstrated decreased femur size
in NOMID relative to WT mice (Fig. 3C).
We also observed the development of a tissue ‘‘spike’’ across the
mid region of the growth plate in NOMID mice (Fig. 3C,
arrowhead). The tissue spike had an average length of
473.66102.6 mm at P13 and was approximately 8.6% of the
average length of the bone, occurring in the femurs and tibiae,
prominent sites of bone deformities in NOMID patients [10,12].
We therefore carried out structural analyses in the metaphyseal
region that included or was contiguous to the spike (Fig. 3D).
Despite the low whole body BMD, there was abundant
trabeculation in the metaphyseal region around the spike in
femurs of NOMID mice, with no difference in trabecular bone
volume (BV/TV) between the genotypes (Fig. 3E and Fig. S4A,
S4C and S4E). In contrast, trabecular bone mass in the region
contiguous to the spike area was .80% reduced in NOMID mice
compared to control littermates (Fig. 3F and Fig. S4B, S4D and
S4F). Remarkably, NOMID mice also exhibited significantly
lower cortical area and thickness relative to WT mice (Fig. 3G and
3H).
Histologic examination of the femurs from P13 mice confirmed
the presence of the tissue spike in the center of the growth plate,
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spike was acellular and stained in a gradient manner by the
cartilage specific stain, safranin O (Fig. 4A). The thickness of the
hypertrophic zone of the growth plate was reduced in NOMID
compared to WT mice (Fig. 4A and 4B). Hypertrophic
chondrocytes of NOMID mice showed a high degree of apoptosis,
evidenced by TUNEL staining, particularly in the area surround-
ing the spike (Fig. 4C). Interestingly, H&E staining of P8 bones
Figure 1. NOMID mice exhibit growth retardation, perinatal death and inflammation in the joints. Body weight (A) and survival (B) were
monitored daily for 3 weeks (22–25 mice/genotype). NOMID mice demonstrated significantly reduced body weight compared to WT mice by day 5,
and most died by 2 weeks of age. (C) H&E staining of the knee joints from P8 mice. Original magnification, 610. NOMID mice displayed massive
leukocytic infiltrates in the joints and surrounding tissues (arrows).
doi:10.1371/journal.pone.0035979.g001
Figure 2. NOMID mice develop leukocytosis associated with high levels of inflammatory mediators. Complete blood cell counts (A) and
serum cytokine analysis (B) were carried out on samples harvested from P12–13 mice (n=4–7). NOMID mice developed neutrophilia, lymphopenia,
thrombocytosis and anemia and produced higher levels of several inflammatory mediators. G-CSF values were extrapolated beyond the standard
range. IL-6 and TNF-a levels were near statistical significance between genotypes. Data are expressed as mean 6 S.E.M. *P,0.05, **P,0.007. WBC,
white blood cells; RBC, red blood cells.
doi:10.1371/journal.pone.0035979.g002
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the epiphysis of the distal femur and proximal tibia (Fig. 4D and
4E). We observed the development of the spike in 12 out of 12
NOMID mice, but in 0/15 WT siblings. In P8 bones, the
expression patterns of type I collagen and type X collagen,
components of the extracellular matrices of bone and the
hypertrophic zone, respectively, were indistinguishable between
WT and NOMID mice, although the hypertrophic zone was
thinner in NOMID especially in the mid region (Fig. 5A and 5B).
Interestingly, the staining of type II collagen, which is selectively
expressed by chondrocytes, was reduced in the central zone of the
epiphysis, with a void corresponding to the acellular area (Fig. 5C).
The region of the tissue spike below the growth plate stained
positively for type I collagen, particularly in P13 femurs (Fig. 5D).
Thus, safranin O gradient staining patterns coupled with type I
collagen staining and the mCT evidence suggest that the spike
contained elements of bone and cartilage matrices.
NOMID mice develop inflammation in bone marrow
resulting in increased bone resorption
The decreased trabecular bone volume (Fig. 3F) and cortical
area and thickness (Fig. 3G and 3H) in NOMID mice may be the
result of increased bone resorption, decreased bone formation or
both. However, the disproportionately increased bone marrow
cavity relative to the small bone size of NOMID mice (Fig. 6A)
suggests increased bone resorption. Consistent with this notion, we
observed abundant tartrate-resistant acid phosphatase (TRAP)
positive OC in the primary spongiosa and on the endocortical
bone surface of NOMID compared to WT mice (Fig. 6B).
Quantitative analysis indicated significantly increased OC number
(Fig. 6C) and OC surface (a reflection of OC size) (Fig. 6D) in
NOMID mice, associated with a 4-fold increase in the serum levels
of C-telopeptide of type I collagen (CTX-1), a marker of bone
resorption, compared to WT mice (Fig. 6E).
Consistent with constitutively activated NLRP3, IL-1b levels in
fluid obtained by centrifuging bone marrow were approximately
3-fold higher in NOMID compared to WT mice (Fig. 6F),
indicative of inflammation in the bone marrow. Accordingly,
FACS analysis revealed that the number of cells expressing
neutrophil markers (CD11b
+/Gr1
+ or CD11b
+/Ly6G
+)o r
inflammatory monocyte markers (CD11b
+/Ly6C
+) was increased
in NOMID bone marrow compared to WT (Fig. S5). Within these
cell populations (Fig. 7C and 7D), the number of CD11b
low/
Gr1
low/CD117
+ cells, those with higher potential to form OC, was
increased in NOMID bone marrow (Fig. 7E), but not CD11b
high/
Gr1
high/CD117
+ cells (Fig. 7F). These data are consistent with
neutrophilia (Fig. 2A) and an increase in the number of OC in
NOMID mice. Thus, inflammation-associated bone resorption
accounts at least in part for the low bone mass of NOMID mice.
NLRP3 inflammasome and its effectors are expressed by
the OC and OB lineages
To delineate the expression profile of the NLRP3 inflamma-
some and its effectors in bone cells, we performed RT-PCR
analyses on cDNA generated from OC and OB lineages. IL-1b
and IL-18 messages were expressed by WT OC and OB lineages
as was TLR-4 mRNA (Fig. S6). Importantly, Western blotting
analysis revealed that NLRP3 protein expression was maintained
throughout the differentiation of WT OC (Fig. 7G) and OB
though its levels were slightly lower in OB (Fig. 7H). In addition,
our results show up-regulation of NLRP3 expression in the OC
and OB lineages by LPS (a TLR-4 ligand) and TNF-a,
Figure 3. NOMID mice exhibit stunted skeletal growth and reduced bone mass. X-ray radiography (A), DXA (B)o rmCT analysis of the femur
(C, E–H) of NOMID and WT mice at age P13. DXA and mCT 3D reconstruction revealed generalized osteopenia and the presence of a tissue spike
across the growth plate (C, arrowhead) in 2 NOMID mice. (D) The metaphyseal region containing (E) or contiguous (F) to the spike (depicted in black
in Fig. 3D) where trabecular bone volume (BV/TV) was quantified. BV/TV was unchanged in the metaphyseal region that included the spike, but was
decreased in the region contiguous to this structure. NOMID mice also exhibited significantly lower cortical area (G) and thinner cortical bone (H).
Quantitative data were obtained from 5–6 mice/genotype and expressed as the mean 6 S.E.M. *P,0.05; **P,0.007. BMD, bone mineral density.
doi:10.1371/journal.pone.0035979.g003
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PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e35979Figure 4. NOMID mice exhibit disorganized growth plates. Femoral sections from P13 (A–C)o rP 8( D and E) mice were used for safranin O (A)
and H&E (B, D and E) staining or for TUNEL (C). Original magnification:620 (A and C),610 (B, D and E). The spike (arrowhead) and early morphological
changes (D, arrowhead) were observed only in NOMID mice. NOMID cells showed a high degree of apoptosis. hz, hypertrophic zone.
doi:10.1371/journal.pone.0035979.g004
Figure 5. Type II collagen staining is reduced in the acellular structure in NOMID mice. Femoral sections from P8 (A, B and C) or P13 mice
(D) were stained for types I, X (green), II (red) collagen, and counterstained with DAPI (blue). Type II collagen staining was not observed in the
acellular structure within the cartilage zone above the hypertrophic chondrocyte zone (hz). Original magnification: 620 (A and B), 610 (C and D).
doi:10.1371/journal.pone.0035979.g005
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PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e35979Figure 6. Bone resorption is increased in NOMID mice. Femoral sections from P13 mice were stained with H&E (A) or for TRAP activity (B–D),
and OC number (C) or surface (D) per bone surface was determined. NOMID mice exhibited a larger bone marrow cavity in relation to overall bone
size compared to WT mice (A). Abundant OC (stained in red, B) were present in the primary spongiosa and on the endocortical bone surface of
NOMID mice. There were fewer trabeculae (T) and thinner cortical bone (bracket) in NOMID compared to WT mice. Original magnification:62( A),610
(B, trabecular region), 620 (B, cortical region). Serum was collected for the measurement of CTX-1 levels (E), and supernatants were collected from
centrifuged bone marrow for the measurement of IL-1b (F). CTX-1 and IL-1b levels were 3- to 4-fold higher in NOMID compared to WT mice.
Quantitative data were obtained from 5 mice/genotype and expressed as the mean 6 S.D. (C, D and F) or mean 6 S.E.M. (E). *P,0.05; **P,0.007.
doi:10.1371/journal.pone.0035979.g006
Figure 7. NOMID mice exhibit inflammation in the bone marrow, and bone cells express NLRP3. Bone marrow cells were unstained (A
and B) or stained with antibodies against CD11b, Gr1 or CD117 (C and D). The expression of CD117 was analyzed by gating cells expressing low levels
(E) or high levels (F) of CD11b and Gr1. The number of CD11b
low/Gr1
low/CD117
+ cells, but not CD11b
high/Gr1
high/CD117
+ cells, was increased in
NOMID mice. Flow cytometry experiments were repeated up to 4 times with similar results. (G) BMM were induced to differentiate into OC in the
presence of M-CSF and 100 ng/ml RANKL for the indicated times, and some cultures were further stimulated with 100 ng/ml LPS for 24 hours. (H)
BMSC were induced to differentiate into OB for 1 or 7 days, and some cultures were then stimulated with 20 ng/ml TNF-a for 24 hours. Western blot
analysis shows that NLRP3 expression was maintained throughout cell differentiation and was up-regulated by LPS or TNF-a. b-actin was used as a
protein loading control.
doi:10.1371/journal.pone.0035979.g007
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is regulated by inflammatory stimuli in vitro.
OC differentiation in vitro is increased in NOMID cells
Next, we studied OC differentiation in vitro from unfractionated
bone marrow cells. We found that RANKL and M-CSF-
stimulated OC differentiation was significantly higher in NOMID
cells compared to WT (Fig. 8A). To determine whether this is due
to an increase in the number of OC precursors, hyper-
responsiveness of these cells to M-CSF and RANKL or a
combination thereof, we studied OC formation using bone
marrow-derived macrophages (BMM). NOMID BMM formed
more OC than WT cells in response to RANKL and M-CSF
treatment (Fig. 8B). Co-culturing NOMID BMM with WT bone
marrow stromal cells (BMSC) also resulted in a significantly higher
number of OC relative to co-cultures of WT BMM and WT
BMSC (Fig. 8C), suggesting that NOMID BMM have a higher
predisposition to differentiate into OC.
Next, we determined the ability of OC precursors to respond to
M-CSF-induced mitogenic and survival signals. We observed that
unfractionated NOMID bone marrow cells proliferated signifi-
cantly less in response to M-CSF than their WT counterparts
(Fig. 9A), in agreement with a recent report indicating that OC
precursors with higher osteoclastogenic potential are less respon-
sive to the mitotic effect of M-CSF [22]. Within a 96-hour
timeframe, cell metabolic activity (a reflection of cell proliferation
and survival) was diminished in NOMID cells compared to WT
(Fig. 9B), consistent with the increased levels of cleaved PARP, a
marker of apoptosis, in NOMID cells (Fig. 9C). The overall
decrease in cell survival may reflect neutrophil loss in vitro as these
cells are expected to survive poorly in such experimental
conditions. Interestingly, no difference in cell proliferation and
survival between genotypes was observed when cultured BMM
were used (Fig. 9D and 9E).
It is possible that the increased osteoclastogenesis in NOMID
cells is due to increased activation of key pathways regulating OC
development. To test this hypothesis, we performed Western blot
analyze the activation of NF-kB, Akt, ERK and JNK pathways in
NOMID and WT cells. M-CSF caused a similar degree of ERK
and Akt phosphorylation in WT and NOMID BMM (Fig. S7A),
findings consistent with the mitogenic effects of M-CSF on these
cells. We also found that RANKL-mediated activation of NF-kB,
ERK and JNK pathways was comparable between WT and
NOMID BMM (Fig. S7B). Collectively, these findings support the
hypothesis that the NOMID mutation causes increased osteoclas-
togenesis in vitro independent of hyper-activation of MAPK, NF-
kB and Akt pathways.
Figure 8. OC differentiation is increased in NOMID cells. Unfractionated bone marrow cells (A) or BMM previously cultured for 3 days in the
presence of M-CSF (B) were induced to differentiate into OC in the presence of M-CSF and 100 ng/ml RANKL. (C) Co-cultures of WT or NOMID (NOM)
BMM and WT BMSC were carried out in the presence of 10 nM dexamethasone and 1 nM 1,25(OH)2 vitamin D3 for 5–7 days. The cultures were
stained for TRAP activity, and the number of OC (cells stained in red with $3 nuclei, arrow) were counted manually. The pictures were taken at the
same magnification (64) for both genotypes. The data show that NOMID cells formed more OC than WT cells. Determinations were performed in
triplicate and expressed as the mean 6 S.E.M. Results are representative of at least three independent experiments. **P,0.007.
doi:10.1371/journal.pone.0035979.g008
NLRP3 Inflammasome and Skeletal Development
PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e35979Discussion
The identification of more than 80 disease-associated mutations
in NLRP3 in patients with CAPS underscores the challenges of
genotype-phenotype relationship studies in humans [8,9]. In an
attempt to generate pre-clinical disease-relevant models and
investigate the phenotypic features unique to NOMID including
the characteristic arthropathy and severe CNS sequelae, we
engineered mice expressing a D301N NLRP3 mutation, the
mouse ortholog of a human mutation associated with the most
severe CAPS phenotype, NOMID. NOMID mice were growth
retarded compared to WT littermates and developed systemic
inflammation as evidenced by leukocytosis and increased levels of
multiple inflammatory mediators, demonstrating that D301N is a
gain-of-function mutation as anticipated. In agreement with
previous reports, cytokines associated with T cell activity were
not up-regulated, providing further evidence for the CAPS
paradigm of fully innate immune driven inflammation [20]. The
similarities in cell types, cytokine profiles, and overall gross
phenotype suggest these mice are reasonable models of human
NOMID. While the CNS phenotype of these mice is limited, we
did identify a striking bone phenotype that is the focus of this
current study.
Histologic examination of mouse knee joints revealed neutro-
philic infiltration in the bone marrow, synovium and surrounding
tissue, indicating potential skeletal inflammation. Subsequent
analysis of P13 femurs and tibiae showed severely disorganized
growth plates associated with the development of a tissue spike
across the mid region of the growth plate in all NOMID mice, but
not WT controls. Most cells inside and around this structure were
apoptotic, an observation in agreement with its acellularity and
reduced type II collagen staining. Morphologic changes in
NOMID bones were mostly confined to the center of the epiphysis
at P8. Taken together, these results suggest that increased
chondrocyte apoptosis in the center of the growth plate resulted
in the spike formation. Further studies on the role of NLRP3
mutations on chondrocyte homeostasis are needed and will be
performed by taking advantage of a chondrocyte-specific Cre
recombinase system to limit expression of D301N NLRP3 to cells
involved in skeletal homeostasis. By side-stepping the severe
systemic inflammation caused by universal D301N NLRP3
expression, these mutant mice are likely to live longer, enabling
long-term studies.
The tissue spike developed disproportionally in the knee, as its
size was larger in the femoral distal epiphysis compared to the
tibial proximal epiphysis. We therefore propose that the tissue
spike could ultimately lead to the development of asymmetric knee
deformations as seen in NOMID patients. Interestingly, abnormal
endochondral bone formation in these patients has been suggested,
although the histologic analysis was limited to a single biopsy
Figure 9. Unfractionated NOMID bone marrow cells proliferate and survive significantly less than their WT counterparts.
Unfractionated bone marrow cells (A–C) or BMM (D and E) were cultured in media containing M-CSF for the indicated times. Proliferation (A and D),
metabolic activity (B and E) and Western blot analysis of PARP cleavage (C) were carried out. While unfractionated NOMID cells proliferated and
survived less than WT cells, no differences were seen in BMM proliferation and survival between genotypes. PARP cleavage was higher in NOMID than
in WT cells. Determinations were performed in triplicate and expressed as the mean 6 S.D. Results are representative of three independent
experiments. *P,0.05; **P,0.007 over the control (Ctl).
doi:10.1371/journal.pone.0035979.g009
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one patient [12]. Whether the spike could result in classic NOMID
arthropathy unfortunately could not be determined within the
limited life span of these mice.
We show that the D301N NOMID mutation causes massive
bone resorption, echoing the osteoporosis commonly observed in
NOMID patients [12]. The osteopenia noted in NOMID mice
likely occurred through multiple mechanisms. Indeed, our studies
suggest that the NOMID mutation results in an increased number
of bone marrow OC precursors, perhaps linked to the high levels
of pro-osteoclastogenic cytokines in the bone marrow milieu, but
also heightened sensitivity to osteoclastogenic signals, as demon-
strated by the significantly increased number of OC produced in
vitro by NOMID BMM co-cultured with WT BMSC. The
molecular mechanisms of this increased osteoclastogenesis remain
to be further elucidated not only because we found no difference in
the ability of M-CSF or RANKL to activate several signaling
pathways between NOMID and WT cells, but also because
skeletal lesions in NOMID patients continue despite IL-1b
blockade therapies [23]. In any case, it is likely that this
dramatically increased osteoclastogenesis accounts for most of
the reduced trabecular bone mass and cortical thickness present in
our NOMID mice. It is possible, however, that decreased bone
formation also contributed to the osteopenic phenotype. OB
differentiation studies were hampered by the poor growth of
NOMID bone-forming cells in vitro and OB-related bone
parameters could not be obtained from a P13 immature skeleton.
It is noteworthy that NOMID mice are clearly unhealthy.
Therefore, the skeletal analysis of these mice may be confounded
by a number of factors including low body weight and systemic
inflammation. The development of the tissue spike as a nonspecific
consequence of systemic inflammation cannot be ruled out since
these mice globally express mutant NLRP3, however to the best of
our knowledge, tissue spike has never been reported in any of the
various models of skeletal pathologies associated with systemic
inflammation, such as the TNF trangenic model [24]. Mice
deficient in the phosphatidylinositol 39(IP3)-phosphatase, Pten
have been shown to develop a bony ‘‘bridge’’ [25] structure that
superficially resembles the NOMID tissue spike. However, Pten
deficient mice had no evidence of inflammation and actually
exhibited higher bone mass than controls. No relationship between
the Pten pathway and the inflammasome has been reported.
Irrespective of the underlying mechanisms, our findings provide
some insights on the mechanisms of NOMID-related arthropathy,
which is prominent in the knees and is characterized by large
epiphyseal expansion. Whether the skeletal phenotype is truly
specific to the NOMID mouse, and not found in other Nlrp3
mutant models cannot currently be determined, as mice expressing
MWS and FCAS mutations die even earlier than their NOMID
counterparts [20]. Thus, leveraging strategies confining mutant
NLRP3 expression to certain cell types could further differentiate
mouse mutant NLRP3 phenotypes. Our findings do indeed
establish the validity of this mouse NOMID model and establish
the NLRP3 inflammasome as a major regulator of pathological
bone resorption, opening novel avenues for future investigations
on the mechanisms underlying the skeletal manifestations
associated with NOMID.
Materials and Methods
Generation of NOMID mice
The D301N allele was engineered by site directed mutagenesis
with a Stratagene Quik-change kit using a previously described
strategy [20]. Briefly, the targeting construct
pPNTlox2PNlrp3D301N was created by cloning 4–7 kb regions
directly upstream and downstream of a targeted position in intron
2o fNlrp3 around the neoR antibiotic resistance cassette in plasmid
pPNTlox2P (Fig. S1). 129 SvJ stem cells were electroporated with
linearized pPNTlox2PNlrp3D301N as described previously [20].
Stem cell colonies were selected based upon Southern analysis and
PCR and used to create chimeric mice, which yielded offspring
heterozygous for D301N. Zona pelucida 3-Cre recombinase-
mediated excision of the neoR cassette was confirmed, and mouse
genotyping were performed with PCR. All procedures were
approved by the Animal Studies Committee of the University of
California, San Diego (UCSD), La Jolla, and Washington
University in St. Louis.
Bone mass and microstructure
Whole BMD and femoral bone structure were analyzed by
DXA using a PIXImus scanner (GE/Lunar, Madison, WI) and
mCT system (mCT 40; Scanco Medical AG, Zurich, Switzerland),
respectively, as previously described [26]. For X-ray radiography,
animals were anesthetized, placed in prone and lateral positions
against the Biomax XAR film (Kodak Scientific Imaging), and
exposed to an X-ray at 20 kV for 15 sec using a Faxitron
radiographic system (Faxitron X-ray Corporation). Films were
developed using a Kodak X-OMAT 2000A processor. Micro-Ct
scans were derived as described previously [26]. Briefly, femora
were stabilized in 2% agarose gel and mCT scans taken along the
length of the femur (16 mm voxel size, 16.4 mm diameter, 45 kVp,
145 mA, medium resolution, and 150 ms integration time). The
volume of interest analyzed was located just distal to the physis,
spanning a height of 700 mm each for the metaphyseal region
containing the spike and contiguous to this structure, and
contained all the bone within the cortical shell (Fig. 3D).
Histology, histomorphometry and immunofluorescence
Tissue samples were processed as described previously. Briefly,
bones and brains were fixed in 10% formalin. Bones decalcified in
14% (w/v) EDTA pH 7.2 for 10–14 days at room temperature,
embedded in paraffin, sectioned at 5 mM thickness were mounted
on glass slides. The sections were stained with H&E, TRAP or
safranin O as previously described [27]. Apoptosis was analyzed
using the fluorescein In Situ Cell Death Detection kit (Roche). For
immunofluorescence, P8 limb tissue sections were incubated with
1% hyaluronidase (Sigma) for 30 min at 37uC, rinsed with PBS
and blocked with 10% goat serum for 1 hour at room
temperature. The sections were then incubated overnight at 4uC
with rat polyclonal type II collagen antisera [28], rabbit polyclonal
type I collagen antisera (Abcam) or rabbit polyclonal type X
collagen antisera [29]. After washes in PBS, the sections were
incubated for 1 hour at room temperature with secondary
antibodies conjugated to either Alexa 488 or Alexa 594 fluorescent
dyes (Invitrogen). Following rinses in distilled water, DAPI-
containing mounting solution was applied to each tissue section.
A Nikon Eclipse E800 fluorescence microscope was used to view
the images.
Peripheral blood analysis
Complete blood counts were performed by the UCSD ACP
Diagnostic Laboratory as previously described [20].
Preparation of bone marrow cells
The femora and tibiae were harvested into a-MEM containing
10% FBS (Invitrogen), 100 mg/ml streptomycin and 100 IU/ml
penicillin G (culture media, CellGro) after removal of excess
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cavity by first removing the epiphyses of bones followed by
centrifugation at 13,000 rpm for 30 sec. Cells were then
resuspended in culture medium and filtered to remove debris.
Osteoclast (OC) formation
For OC formation from unfractionated bone marrow cells, cells
(5610
4) were plated in a 96-well plate in culture media containing
a 1:50 dilution of CMG 14–12 supernatant as a source of M-CSF
and RANKL (100 ng/ml) [30]. Media with supplements were
changed every other day for 5–7 days as indicated, and
maintained at 37uC in a humidified atmosphere of 5% CO2 in air.
For OC formation from enriched BMM, bone marrow cells
were maintained in culture media containing a 1:25 dilution of
CMG 14–12 supernatant as a source of M-CSF for 5 days in a 10-
cm dish. Nonadherent cells were removed by vigorous washes with
PBS, and adherent BMM were detached with trypsin-EDTA,
plated at 5–10610
3/well in a 96-well plate, and cultured as
described above.
For co-cultures, BMSC were culture expanded in a-MEM
containing 20% FBS (ATLAS) for 5–7 days. BMSC (37.5610
3)
and BMM (37.5610
3) were plated per well in a 96-well plate in a-
MEM supplemented with 10 nM dexamethasone and 1 nM
1,25(OH)2 vitamin D3 (Sigma) as previously described [31]. Cells
were cultured as described above.
Osteoblast (OB) differentiation
BMSC were induced to differentiate into OB as previously
described [26]. Briefly, BMSC (8610
5) were plated per well in a 6-
well plate in a-MEM supplemented with osteogenic medium
containing 10 mM b-glycerophosphate and 50 mg/ml ascorbic
acid.
Flow cytometry
Mouse bone marrow cells were prepared as described above.
Red blood cells were depleted with red blood cell lysis buffer
(Roche), and fixed in PBS containing 1% bovine serum albumin
and 0.1% sodium azide. Cells (0.5–1610
6) were incubated with
CD16/32 (BioLegend) to block nonspecific Fc binding, stained
with PE-anti-Ly6G monoclonal antibodies (mAbs), Alexa-
FluorH647-anti-CD11b mAbs, PerCP-Cy
TM5.5-anti-CD117
mAbs (BioLegend), PerCP-Cy
TM5.5-anti-Ly6C mAbs or V450-
anti-Gr1 mAbs (BD Pharmingen), according to the supplier’s
instructions. Samples were acquired with a FACSCaliber (BD) or
FACSCanto (BD), followed by analysis with FlowJo software (Tree
Star, Inc.).
Cell proliferation and metabolic activity
Mouse bone marrow cells (5610
4) prepared as described above
were plated in a 96-well plate and treated with M-CSF-containing
supernatant for the indicated times. Proliferation and metabolic
activity were analyzed using the BrdU chemiluminescent ELISA
kit (Roche) and the MTT method (Sigma), respectively.
TRAP staining
Cytochemical staining for TRAP was used to identify OC as
described previously [27,28,32]. Briefly, cells in a 96 well plate
were fixed with 3.7% formaldehyde and 0.1% Triton X-100 for
10 min at room temperature. The cells were rinsed with water and
incubated with the TRAP staining solution (Sigma leukocyte acid
phosphatase kit) at room temperature for 30 min. Multinuclear
TRAP positive cells with at least 3 nuclei were counted under light
microscopy.
Western blot analysis
Mouse BMM (8610
5) were plated per well in a 6-well plate in
media containing 20 ng/ml M-CSF and/or 100 ng/ml RANKL,
and cultured for the indicated times. Some cultures were treated
with 100 ng/ml LPS (Sigma) for 24 hours. Mouse BMSC (1610
6)
were plated per well in a 6-well plate in osteogenic media
containing 10 mM b-glycerophosphate and 5 mg/ml ascorbic acid
for 7 days. At day 1 or day 7, cells were treated with 20 ng/ml of
mouse TNF-a (R&D Systems) for 24 hours. Cell extracts were
prepared by lysing cells with RIPA buffer (50 mM Tris, 150 mM
NaCl, 1 mM EDTA, 0.5% NaDOAc, 0.1% SDS, 1.0% NP-40)
plus phosphatase inhibitors (2 mM NaVO4, 10 mM NaF, 1 mM
PMSF) and Complete Protease Inhibitor Cocktail (Roche). Protein
concentrations were determined by the BioRad method, and equal
amounts of proteins were subjected to SDS-PAGE on 4–12%
NuPAGE gels (Invitrogen). Proteins were transferred onto
nitrocellulose membranes, and incubated with antibodies against
NLRP3 (Adipogen), p-cJun (Santa Cruz Biotechnology), p-ERK
and p-Akt (Cell Signaling) or b-actin (Sigma) for 2 hours at room
temperature, followed by 1 hour incubation with secondary goat
anti-mouse IRDye 800 (Rockland) or goat anti-rabbit Alexa-Fluor
680 (Molecular Probes), respectively. The results were visualized
using Li-Cor Odyssey Infrared Imaging System (Li-Cor).
Immunoassays
Serum cytokine levels were analyzed by Luminex assay (Bio-
Rad) according to the manufacturer’s instructions. Serum CTX-1
levels were quantified using a Rat LAPS EIA kit from
Immunodiagnosticssystems. Bone marrow IL-1b levels were
quantified using the eBiosciences Elisa kit.
Statistical analysis
Statistical significance was assessed by Student’s t test for
independent samples. Values are expressed as mean 6 S.E.M.
unless otherwise stated.
Supporting Information
Figure S1 Generation of the D301N NLRP3 mutant. The
mutant allele was generated as described in Materials and
Methods. The asterisk depicts the mutation in exon 3.
(TIF)
Figure S2 Evidence of meningitis in NOMID mice.
Brains from P13 mice were stained with H&E. NOMID mice
(B) showed a perivascular accumulation of neutrophils (arrows) in
the meninges that is absent in WT mice (A).
(TIF)
Figure S3 Expression of inflammatory mediators in mouse
serum. Serum cytokine analysis (5–7 mice/genotype) was carried
out on samples harvested from P12–13 mice. Data are expressed
as the mean 6 S.E.M. *P,0.05; **P,0.007.
(TIF)
Figure S4 Bone parameters in NOMID and WT mice.
Femoral metaphyseal region that included (A, C and E)o r
extended approximately 700 mm contiguous to the spike (B, D and
F) were analyzed by mCT. Quantitative data were obtained from
5–6 mice/genotype. Trabecular number (Tb.N) and thickness
(Tb.Th) were decreased, and trabecular space (Tb.Sp) was
increased in NOMID mice in the region that is contiguous to
the spike, but not in the region that contains this structure. Data
are expressed as the mean 6 S.E.M. *P,0.05; **P,0.007.
(TIF)
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cells. Bone marrow cells were stained with antibodies against
CD11b or Gr1 (A and B), CD11b or Ly6G (C and D), CD11b or
Ly6C (E and F). The number of CD11b
+/Gr1
+ cells, CD11b
+/
Ly6C
+ cells or CD11b
+/Ly6G
+ cells were approximately 3-fold
higher in NOMID than in WT cells.
(TIF)
Figure S6 Expression of IL-1 family members and TLR4
in bone cells. Bones were harvested from WT or NOMID mice.
RNA was isolated from flushed bone marrow cells (marrow, A and
D), bone marrow-free bones (bone, A, B and D), BMSC induced or
not to differentiate into OB for 2 weeks in vitro (OB, C and E)o r
BMM induced or not to differentiate into OC in vitro for 2 days in
the presence of M-CSF and RANKL (pre-OC, C). RNA
expression was analyzed by PCR. Cells of the OB or OC lineage
expressed IL-1b, IL-18 and TLR4 transcripts.
(TIF)
Figure S7 Activation of signaling pathways by M-CSF or
RANKL in BMM. BMM were treated with 50 ng/ml M-CSF (A)
or 100 ng/ml RANKL (B), and proteins were analyzed by
Western blot. M-CSF-mediated activation of ERK and Akt
pathways or RANKL-mediated activation of ERK, NF-kB and
JNK pathways was comparable between WT and NOMID BMM.
The b-actin band shows that proteins were loaded equally. NS,
non specific.
(TIF)
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